Hinge Health, Inc. (HNGE)

Market Cap	4.35B
Revenue (ttm)	646.34M +49.8%
Net Income	-511.39M
EPS	-7.27
Shares Out	77.38M
PE Ratio	n/a
Forward PE	20.76
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,737,578
Open	55.19
Previous Close	54.95
Day's Range	54.13 - 56.86
52-Week Range	30.08 - 62.18
Beta	n/a
Analysts	Buy
Price Target	70.73 (+25.83%)
Earnings Date	May 5, 2026

About HNGE

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, C...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: May 22, 2025
• Employees: 1,437
• Stock Exchange: NYSE
• Ticker Symbol: HNGE
• Website: https://www.hingehealth.com

Financial Performance

In 2025, Hinge Health's revenue was $587.86 million, an increase of 50.58% compared to the previous year's $390.40 million. Losses were -$424.09 million, 3453.9% more than in 2024.

Analyst Summary

According to 16 analysts, the average rating for HNGE stock is "Buy." The 12-month stock price target is $70.73, which is an increase of 25.83% from the latest price.

Price Target

$70.73

(25.83% upside)

Analyst Consensus: Buy